Skip to content
Companies

Neuro-Kinesis

Biosensor catheters for cardiac electrophysiology

Raised to date

$51K

of $2M offered across 1 Form D filing

Still open
$1.9M
Investors
5
Last filed
Apr 24, 2026

About

Neuro-Kinesis Corporation develops smart surgical tools built around its patented biosensor technology, which converts analog biological signals at the tissue interface into digital data a microprocessor can analyze. Its lead device is the Huygens catheter, a diagnostic catheter that delivers real-time biometric feedback with higher signal resolution for cardiac electrophysiology. The company is also developing the SMARTBrain retractor for neurosurgery and holds the CGCI robotic catheter navigation system, which uses magnetic field energy and real-time 3D mapping and has been CE-marked for sale in Europe. It is based in Inglewood, California and was incorporated in 2022.

Roughly 15 years of patented biosensor development applied at the tip of the instrument, so surgeons get real-time digital readouts of tissue state during a procedure instead of inferring it from lower-resolution downstream signals.

Funding

  • EquityFiled Apr 24, 2026Form D
    $51K/ $2M

Product

Huygens Catheter

Interventional cardiology / electrophysiology device

A diagnostic catheter carrying the company's biosensor, delivering intelligent real-time biometric feedback with enhanced signal resolution and sensor-point data processing during cardiac procedures. Phase one development is complete and animal studies are underway toward clinical validation.

  • Patented biosensor at the catheter tip
  • Real-time biometric feedback during the procedure
  • Enhanced signal resolution over conventional mapping catheters

Built for

Hospitals and surgical centers — interventional cardiologists, electrophysiologists, and neurosurgeons

People on file